Urol. praxi, 2011; 12(4): 265-267 [Interní Med. 2011; 13(6): 275-278]

Daily therapy of erectile dysfunction - who is it for, what are the risks?

MUDr.Ta»ána ©rámková, Ph.D.
Klinika traumatologie LF Masarykovy univerzity, Úrazová nemocnice Brno

Erectile dysfunction (ED) is defined as an inability to achieve and maintain an erection sufficient for satisfactory sexual intercourse.

Phosfodiesterase type 5 (PDE5) inhibitors are first line oral medication for erectile dysfunction (ED). Tadalafil 5 mg was well tolerated

and effective in clinical studies, it was alternative to the current on-demand dosing of tadalafil for men with ED. Patients and their sexual

partners preferred once daily administration, mainly because longer efficacy, safety allowing a more spontaneous sexual life.

Keywords: erectile dysfunction, PDE-5 inhibitors, tadalafil

Published: August 10, 2011  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
©rámková T. Daily therapy of erectile dysfunction - who is it for, what are the risks? Urol. praxi. 2011;12(4):265-267.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Kratochvíl S. Léčení sexuálních dysfunkcí. Praha, GradaPublishing: 1999; 249 s.
    2. Breza J. Erektilné poruchy. Osveta, Martin, 1994: 270 s.
    3. Zámečník L, a kol. Praktická andrologie dospělých. Praha, Mladá fronta; 2010: 254 s.
    4. Zvěřina J. Sexuální dysfunkce. In Weiss P. (ed) Sexuologie. Praha, Grada Publishing, 2010: 339-363.
    5. Washington SL 3rd, Shindel AW. A once daily dose of tadalafil for erectile dysfunction: compliance and efficacy. Drug Devel Ther; 2010; 7(4): 159-171. Go to original source...
    6. De Bon E, Bonanni G, Saggiorato G, et al. Effects of tadalafil on platelets and endothelium in patients with erectile dysfunction and cardiovascular risk factors: a pilot study. Angiology 2010; 61(6): 602-606. Go to original source... Go to PubMed...
    7. McMahon Ch. Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil. J Sex Med; 2004; 1: 292-300. Go to original source... Go to PubMed...
    8. Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol; 2006; 50: 351-359. Go to original source... Go to PubMed...
    9. Shabsigh R, Donatucci R, Costabile MA, et al. Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success. Int J Impot Res; 2010; 22: 1-8. Go to original source... Go to PubMed...
    10. Porst H, Rajfer J, Casabé A, et al. Long-term safety and efficacy of tadalafil 5 mg dosed one daily in men with erectile dysfunction. J Sex Med; 2008; 5(9): 2160-2169. Go to original source... Go to PubMed...
    11. Porst H, Hell-Momeni K, Buttner H. Chronic PDE-5 inhibition in patients with erectile dysfunction: new treatment approach using once daily tadalafil. Urologe A; 2009; 48(11): 1320-1329. Go to original source...
    12. Althof SE, Rubio-Aurioles E, Kingsberg S, et al. Impact of tadalafil once daily in men with erectile dysfunction - including a report of the partner s evaluation. Urology 2010; 75(6): 1358-1363. Go to original source... Go to PubMed...
    13. Pohanka M, Sejbalová P, Crha I, et al. Účinek tadalafilu na parametry spermiogramu u muľů s erektilní dysfunkcí. Prakt Gyn; 2010; 14(4): 164-166.

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.